Back
SpringWorks Therapeutics Vs. Novartis AG Industry Stock Comparison
Sell
37
SWTX
SpringWorks Therapeutics
Last Price:
$48.43
Seasonality Move:
8.06%
Buy
73
NVSEF
Novartis AG
Last Price:
$116.60
Seasonality Move:
6.56%
Sell
37
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $49.89. The Score for SWTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $49.89The current trend is moderately bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
SWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.61 | Buy |
Relative Strength Index (14 RSI): | 49.34 | Sell |
Chaikin Money Flow: | -951970 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.84 | Buy |
Relative Strength Index (14 RSI): | 61.26 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.1 - 113.78) | Buy |
Bollinger Bands (100): | (98.55 - 109.41) | Buy |
SWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.28 | Sell |
20-day SMA: | 52.34 | Sell |
50-day SMA: | 46.03 | Buy |
200-day SMA: | 38.9 | Buy |
8-day EMA: | 50.48 | Sell |
20-day EMA: | 50.66 | Sell |
50-day EMA: | 47.38 | Buy |
200-day EMA: | 40.82 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.96 | Buy |
20-day SMA: | 111.23 | Buy |
50-day SMA: | 106.01 | Buy |
200-day SMA: | 106.77 | Buy |
8-day EMA: | 112.31 | Buy |
20-day EMA: | 110.66 | Buy |
50-day EMA: | 107.55 | Buy |
200-day EMA: | 104.74 | Buy |
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SpringWorks Therapeutics Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |